Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Isoniazid induced neuropathy: consider prevention].

O Steichen1, L Martinez-Almoyna, T De Broucker

  • 1Service de Neurologie, Centre Hospitalier Delafontaine, Saint Denis, France.

Revue Des Maladies Respiratoires
|June 22, 2006
PubMed
Summary

Isoniazid-induced neuropathy, a common side effect of tuberculosis treatment, can be prevented and treated with pyridoxine. Slow acetylator status necessitates lower isoniazid doses to avoid nerve damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shift in emergency department utilization by frequent attendees with sickle cell disease during the COVID-19 pandemic: A multicentre cohort study.

British journal of haematology·2024
Same author

"SCULP" study: The benefits of skin graft pellets on the pain of sickle cell leg ulcers (SCLU).

Journal de medecine vasculaire·2023
Same author

Medical demography at stroke centers: Current situation in France.

Revue neurologique·2023
Same author

[Prevention of pertussis in newborns: Should pregnant women be vaccinated at each pregnancy?]

La Revue de medecine interne·2023
Same author

[Hypertension: Who to treat, to what extent and how?]

La Revue de medecine interne·2023
Same author

[Focal neurological deficits and livedo].

La Revue de medecine interne·2023

Area of Science:

  • Neurology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antitubercular therapy is crucial but associated with adverse effects.
  • Isoniazid-induced neuropathy is a significant and preventable complication.
  • Risk factors for neuropathy include HIV, alcoholism, and diabetes.

Observation:

  • A 42-year-old HIV-positive female patient developed distal leg pain and sensory impairment.
  • Symptoms emerged three months after commencing antitubercular treatment.
  • The patient exhibited slow acetylator status, a known risk factor.

Findings:

  • Reducing isoniazid dosage and administering pyridoxine led to symptom resolution.
  • Pyridoxine demonstrated both preventative and curative effects.

Related Experiment Videos

  • Slow acetylator status correlated with increased neuropathy risk.

    • Implications:

    • Early recognition and management of isoniazid neuropathy are vital.
    • Pyridoxine supplementation should be considered in at-risk patients.
    • Personalized dosing based on acetylator status can mitigate neurotoxicity.